NCT00566150View on ClinicalTrials.gov

Levetiracetam in the Management of Bipolar Depression

NACompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Bipolar Depression
Interventions
DRUG

Levetiracetam

Flexible dose up to 2500mg per day, for 6 weeks.

DRUG

Placebo

Flexible dose up to 2500mg per day, for 6 weeks.

Trial Locations (1)

06519

Yale University School of Medicine, New Haven

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Yale University

OTHER

NCT00566150 - Levetiracetam in the Management of Bipolar Depression | Biotech Hunter | Biotech Hunter